-
公开(公告)号:EP3340982A1
公开(公告)日:2018-07-04
申请号:EP16840164.4
申请日:2016-08-25
发明人: WILES, Jason, Allan , PHADKE, Avinash, S. , DESHPANDE, Milind , AGARWAL, Atul , CHEN, Dawei , GADHACHANDA, Venkat, Rao , HASHIMOTO, Akihiro , PAIS, Godwin , WANG, Qiuping , WANG, Xiangzhu , GREENLEE, William
IPC分类号: A61K31/40 , A61K31/167 , A61K31/395 , C07D401/14 , C07D403/14 , C07D471/04
CPC分类号: C07D209/12 , A61K45/06 , A61P1/16 , C07D207/16 , C07D231/56 , C07D401/06 , C07D401/12 , C07D403/06 , C07D403/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04 , C07D513/04
摘要: Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I″ and I′″ or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.
-
2.
公开(公告)号:EP3589628A1
公开(公告)日:2020-01-08
申请号:EP18761960.6
申请日:2018-03-01
发明人: WILES, Jason, Allan , PHADKE, Avinash, S. , DESHPANDE, Milind , AGARWAL, Atul , CHEN, Dawei , GADHACHANDA, Venkat, Rao , HASHIMOTO, Akihiro , PAIS, Godwin , WANG, Qiuping , WANG, Xiangzhu , BARRISH, Joel, Charles , GREENLEE, William , EASTMAN, Kyle, J.
IPC分类号: C07D403/08 , C07F9/572
-
3.
公开(公告)号:EP3340983A1
公开(公告)日:2018-07-04
申请号:EP16840165.1
申请日:2016-08-25
发明人: WILES, Jason, Allan , PHADKE, Avinash, S. , DESHPANDE, Milind , AGARWAL, Atul , CHEN, Dawei , GADHACHANDA, Venkat, Rao , HASHIMOTO, Akihiro , PAIS, Godwin , WANG, Qiuping , WANG, Xiangzhu , GREENLEE, William
IPC分类号: A61K31/40 , A61K31/167 , A61K31/395 , C07D401/14 , C07D403/14 , C07D471/04
CPC分类号: C07D403/04 , A61P1/16 , A61P29/00 , A61P37/00 , C07D401/14 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/14 , C07D407/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D487/22 , C07D493/04 , C07D513/04 , C07D519/00 , C07F9/65583
摘要: Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I″ and I′″ or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.
-
-